30
Participants
Start Date
October 23, 2020
Primary Completion Date
February 4, 2023
Study Completion Date
May 4, 2023
Labetalol
10 - 20 mg IV q15 minutes PRN until systolic BP below target (max 300 mg per 24 hours)
Hydralazine
10 - 20 mg IV bolus q20 min until systolic BP below target (max 240 mg per 24 hours)
Enalapril
1.25 - 2.5 mg IV bolus and then q6h PRN.
Hamilton General Hospital, Hamilton
Hamilton Health Sciences Corporation
OTHER